Special Issue: “Bench to bedside transition for pharmacological regulation of NRF2 in non-communicable diseases’” 

ISSUEmarzo
Share on facebook
Share on twitter
Share on linkedin

Bench to bedside transition for pharmacological regulation of NRF2 in non-communicable diseases’

The special issue entitled “Bench to bedside transition for pharmacological regulation of NRF2 in non-communicable diseases“,  edited by Prof. Antonio Cuadrado (Autonomous University of Madrid, Spain), Prof. Albena Dinkova-Kostova (University of Dundee, UK), and Prof. Giovanni E. Mann (King’s College London, UK), is offered by the journal Free Radical Biology & Medicine published by Elsevier (impact factor 7.376). This Special Issue aims at integrating and disseminating novel advances in NRF2 knowledge and provides translational insights into the use of selective drugs and tools related to NRF2 pharmacology. It will contain invited review articles and primary papers from members of the BenBedPhar network, and will therefore represent an excellent collection of basic and clinical sciences in the field of NRF2 and related redox medicine issues. The deadline for the manuscript submission is June 1st, 2022.

Summary